From Name:
From Email:
To Name:
To Email:

Optional Message:

Merck's blockbuster drug Keytruda approved to treat head and neck cancer

from Becker's Hospital Review

The Food and Drug Administration today approved Kenilworth, N.J.-based Merck's best-selling cancer drug Keytruda for additional indications. The drug, currently used for the treatment of melanoma and lung cancer, is now also approved for patients with recurrent or metastatic head and neck squamous cell carcinoma with disease progression on or after platinum-containing chemotherapy. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063